Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shiri Zakin"'
Autor:
Alexander Rosenberg, Iuliana V. Ene, Maayan Bibi, Shiri Zakin, Ella Shtifman Segal, Naomi Ziv, Alon M. Dahan, Arnaldo Lopes Colombo, Richard J. Bennett, Judith Berman
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-14 (2018)
The authors show that antifungal tolerance, defined as the fraction of growth of a fungal pathogen above the minimal inhibitory concentration, is due to the slow growth of subpopulations of cells that overcome drug stress, and that high tolerance is
Externí odkaz:
https://doaj.org/article/68c73745174b466d8c1263316f2a3412
Autor:
Ronen Ben-Ami, Judith Berman, Ana Novikov, Edna Bash, Yael Shachor-Meyouhas, Shiri Zakin, Yasmin Maor, Jalal Tarabia, Vered Schechner, Amos Adler, Talya Finn
Publikováno v:
Emerging Infectious Diseases, Vol 23, Iss 2, Pp 195-203 (2017)
Candida auris and C. haemulonii are closely related, multidrug-resistant emerging fungal pathogens that are not readily distinguishable with phenotypic assays. We studied C. auris and C. haemulonii clinical isolates from 2 hospitals in central Israel
Externí odkaz:
https://doaj.org/article/d25fb136565a4f7faa42205518361e9c
Autor:
Shiri Zakin, Arnaldo Lopes Colombo, Naomi Ziv, Judith Berman, Maayan Bibi, Alon Dahan, Richard J. Bennett, Alexander Rosenberg, Ella Shtifman Segal, Iuliana V. Ene
Drug susceptibility, defined by the minimal inhibitory concentration (MIC), often does not predict whether fungal infections will respond to therapy in the clinic. Tolerance at supra-MIC antifungal drug concentrations is rarely quantified and current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e061dee1540145d7c165eb671c102988
Publikováno v:
Open Forum Infectious Diseases. 3